Walking, Outings, and Future Long-Term Care Costs

Walking and getting out may say more about an older adult's future care needs than any wearables' step-count leaderboard. In a large Japanese cohort, older adults who walked more than 60 minutes a day or went out almost daily later accumulated lower public long-term care insurance costs than peers at the lowest activity levels. The gap was substantial—about USD 1,100 for walking and USD 700 for going out—but the studies show association, not proof that a daily walk cuts a future care bill.

That distinction matters. People who can walk, socialize, and leave home often begin with advantages that are hard to measure fully: better health, less early frailty, safer neighborhoods, stronger social ties, or more support at home. Mobility is still worth treating as a serious health target. The evidence just does not permit the cleaner, more marketable claim that walking itself has been proven to save long-term care dollars.

A cost endpoint, not a fitness surrogate

The central evidence comes from Hirai et al.'s 2021 prospective JAGES study. Researchers linked baseline surveys with municipal long-term care insurance claims for 38,875 community-dwelling Japanese adults aged 65 or older. Participants were functionally independent and were not using long-term care insurance at baseline. The study followed them across 59 monthly time points, roughly five years.

Japan's long-term care insurance system pays for insured services after a person receives certification for care need. That gives this study a more concrete endpoint than grip strength, step counts, or a questionnaire score: cumulative insured-service spending. It does not include every cost of aging. Food, housing, non-covered services, and usual co-payments sit outside the claims total. It also cannot be translated dollar-for-dollar to U.S. long-term care spending.

After adjustment for measured demographic, socioeconomic, health, function, and depression variables, people who went out almost every day had mean cumulative insured costs of about USD 2,300, compared with about USD 3,000 among those who went out once a week or less. People reporting more than 60 minutes of daily walking had mean costs of about USD 2,100, compared with about USD 3,200 among those walking less than 30 minutes daily.

The corresponding gap was about USD 700 for infrequent outings and about USD 1,100 for the lowest walking category relative to the most active reference groups. The study also found lower rates of long-term care certification—the gateway to insured care spending—in the more active groups. Certification rates were 24.3 versus 51.2 per 1,000 person-years for almost-daily outings versus outings once a week or less. For walking more than 60 minutes versus less than 30 minutes daily, rates were 19.7 versus 39.3 per 1,000 person-years.

Those paired findings make the pattern plausible: people who remained mobile were less likely to enter the care-certification system and therefore tended to generate less insured spending. But a plausible pathway is not a randomized result.

The largest signal sits at the low-activity end

The study does not support a tidy rule in which every additional minute walked produces a predictable reduction in future care costs. In the primary generalized linear model, walking 30 to 59 minutes per day did not differ significantly from walking more than 60 minutes per day. The going-out comparison between two to three times weekly and almost daily also became borderline in the multiple-imputation analysis.

That is a meaningful limitation, not a footnote. The most defensible interpretation is that very low mobility identified a group with substantially higher later care costs and certification rates. The data do not establish a smooth dose-response curve or identify a magic threshold at 60 minutes.

Self-report also blurs the exposure. A single question about daily walking cannot distinguish pace, terrain, purpose, intensity, balance demands, or whether someone walked to meet friends versus around a flat indoor corridor. The study's results are useful because its outcome was real-world care spending; its exposure measurement remains coarse.

Walking is part of a larger package

Other JAGES evidence argues against treating walking as an isolated ingredient. In a separate 2021 prospective cohort study by Saito et al., frequent hobby participation and sports-group participation were each associated with roughly USD 1.18 thousand to USD 1.23 thousand lower cumulative long-term care insurance cost per person than nonparticipation over six years. Volunteer participation showed non-monotonic patterns, which further weakens any claim that more activity always means better outcomes.

Social participation may help preserve routines, motivation, physical activity, and connection. It may also identify people who already have more functional reserve. Either explanation can contribute to the observed cost difference. A walk undertaken to visit a friend is not biologically identical to a walk undertaken because a clinician prescribed it, even if the duration matches.

Neighborhood conditions may shape the same pattern. Mori et al.'s longitudinal JAGES analysis linked favorable built environments with lower frailty risk and examined daily walking time, depressive symptoms, and social support as mediating factors. Access, safety, mood, and social infrastructure can all affect whether an older adult gets outside. Calling the result a matter of personal discipline would confuse a behavioral marker with the conditions that make that behavior possible.

Disability studies support the direction, not the cost estimate

Several prospective Japanese cohorts connect activity with later disability or frailty. These studies strengthen the idea that mobility could lie on the path to lower care use, but they do not independently calculate the dollar gap seen in Hirai et al.

In a 2024 prospective cohort study by Seino et al., 7,480 initially non-disabled older adults experienced 1,001 incident long-term-care-insurance-defined functional disability events over a median 3.6 years. Higher moderate-to-vigorous physical activity was associated with lower disability risk. The lowest reported hazard ratio was 0.61 at roughly 3,000 to 4,000 MET-minutes per week, compared with no moderate-to-vigorous activity. The result was not a straight-line "more is always better" curve, and sedentary-time associations were weaker, more heterogeneous, and not significant among frail participants.

Ito et al.'s Ohsaki Cohort analysis also found that more walking time predicted longer disability-free survival in older Japanese adults. Meanwhile, Chen et al.'s nine-year accelerometer study found that more objectively measured sedentary behavior predicted higher risk of functional disability among 1,687 Japanese adults aged 65 or older without disability at baseline. Objective measurement helps address recall error, but this study measured disability rather than care spending.

Frailty evidence points in the same general direction with an important wrinkle. In Zhao et al.'s cohort of 485 community-dwelling adults aged 70 to 74, moderate physical activity predicted lower later frailty incidence over three years. Daily walking time showed a U-shaped association with frailty scores, and walking 0.5 to 1 hour daily had a stronger association with lower frailty risk than higher walking levels. That finding is another reason to avoid turning the evidence into a universal volume prescription.

Why causation remains unsettled

Hirai et al. adjusted for age, sex, marital status, education, income, chronic conditions, basic physical function, self-rated health, and depression. Those adjustments improve the comparison, but they cannot erase residual confounding. The analysis did not directly adjust for baseline cognition, detailed social support, living arrangement, or neighborhood walkability and access. Each could influence both how often someone walks or goes out and their later need for care.

The researchers also reduced, but could not eliminate, reverse causation. They excluded people already dependent in activities of daily living, people who died or entered long-term care insurance within one year, and movers. Early disease or subclinical frailty can still reduce outings before formal certification begins.

Cost modeling poses another challenge: about 85% of participants had zero long-term care insurance cost during follow-up. Such a heavily zero-inflated outcome is sensitive to modeling assumptions. The published findings point in one direction, but precision details such as confidence intervals for the adjusted cost contrasts are not reported in the information available here.

Mobility is a credible marker of future independence. The available evidence does not isolate how much of the later cost difference walking itself causes.

A practical reading of the evidence

For older adults, families, clinicians, and communities, a drop in walking or going out deserves attention. It can signal emerging frailty, pain, depression, cognitive change, unsafe streets, loss of transportation, or social isolation—often before a formal care need appears. The response should match the likely barrier: a mobility assessment, medication review, fall-risk evaluation, rehabilitation plan, companion, accessible transport, or a safer route may matter as much as telling someone to take more steps.

The evidence supports making everyday mobility and social participation priorities. It does not support selling walking as a proven long-term-care-cost intervention. Stronger evidence would link repeated objective activity measures to later spending and test whether interventions that increase everyday mobility reduce disability or care use. A 2025 randomized trial of motivational interviewing after hip fracture tested a way to increase activity during rehabilitation, but it does not answer the long-term care cost question.

For now, the clearest fact is observational: in older Japanese cohorts, people who keep walking, going out, and participating in life tend to remain disability-free longer and later use less insured long-term care. That makes mobility worth protecting—without pretending the claims data have settled the cause.